Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors

Beverly L. Falcón(Eli Lilly (United States)), Donald M. McDonald(UCSF Helen Diller Family Comprehensive Cancer Center)
Cancer Research
March 1, 2011
Cited by 91


Related Papers